01.12.2006 | ORIGINAL ARTICLE
p53 expression status is a significant molecular marker in predicting the time to endocrine therapy failure in recurrent breast cancer: a cohort study
Erschienen in: International Journal of Clinical Oncology | Ausgabe 6/2006
Einloggen, um Zugang zu erhalten